CMA Regulatory Advocacy Report 2026

Every year, CMA works across dozens of regulatory consultations, government reviews, technical committees and policy discussions to ensure the interests of Australia’s complementary medicines industry are represented.

Our 2026 Regulatory Advocacy Report provides a comprehensive overview of that work, highlighting the issues CMA has been advocating on, the progress achieved over the past year and the outcomes delivered for members and the broader industry.

From ingredient scheduling and labelling reforms through to manufacturing standards, advertising, exports and international market access, the report demonstrates how CMA is helping shape a regulatory environment that supports consumer safety, innovation and industry growth.

You can view or download the report below.